Neuropeptide Y expression in primary cutaneous melanoma

Area of Science:

• Oncology
• Dermatology
• Molecular Biology

Background:

• Neuropeptide Y (NPY) plays a role in the development of various tumors, particularly those originating from neural crest cells.
• Melanoma, a significant skin cancer, is influenced by various molecular factors during its carcinogenesis.

Purpose of the Study:

• To investigate the expression levels of Neuropeptide Y (NPY) in melanoma tissues.
• To determine the relationship between NPY expression and key prognostic histological parameters in melanoma.
• To assess the correlation of NPY expression with patient survival outcomes in melanoma.

Main Methods:

• A retrospective observational study was conducted on 79 primary melanomas from two independent Spanish university hospitals.
• Data were collected from January 2000 to December 2004.
• Histological parameters, including tumor thickness, cell proliferation (Ki-67), mast cell density, E-cadherin expression, and NPY expression, were analyzed.

Main Results:

• Higher NPY expression was observed in superficial spreading melanoma and lentigo maligna (40%).
• Increased NPY expression was associated with thinner tumors (lower Clark and Breslow levels).
• Low NPY expression correlated with high cell proliferation (Ki-67), high peritumoral mast cell density, and low E-cadherin expression. Melanomas with high NPY expression showed significantly longer relapse times (114 vs. 68 months) and better overall survival (114 vs. 74 months).

Conclusions:

• High Neuropeptide Y (NPY) expression in melanoma is associated with favorable prognostic histological features.
• Elevated NPY levels correlate with reduced peritumoral mast cell density and the presence of adhesion proteins like E-cadherin.
• Higher NPY expression in melanoma patients indicates a better prognosis and improved survival outcomes.